Brief: Redcare Pharmacy NV Sees 2026 Total Revenue Growth Of 13% To 15%
03/03/2026 21:34
March 3 (Reuters) - Redcare Pharmacy NV RDC.DE: EQS-ADHOC: REDCARE PHARMACY N.V. ANNOUNCES GUIDANCE FOR 2026. REDCARE PHARMACY NV - SEES 2026 TOTAL REVENUE GROWTH OF 13% TO 15% REDCARE PHARMACY NV - SEES 2026 ADJUSTED EBITDA MARGIN OF AT LEAST 2.5% REDCARE PHARMACY NV - SEES 2026 NON-RX REVENUE GROWTH OF 8% TO 10% Source text: ID:nEQ4Yqsxza Further company coverage: RDC.DE ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Redcare Pharmacy NV
See all newsNetherlands' Redcare Pharmacy slightly beats Q3 revenue estimates on strong prescription sales in Germany
Brief: Redcare Pharmacy Q3 Sales EUR 847 Million
Brief: Redcare Pharmacy Appoints Peter Schmid Von Linstow As CEO
Europe Research Roundup: DEUTZ, Legrand, VAT
Brief: Redcare Pharmacy Now Expects FY Total Revenue Growth of 16% to 18%